Skip to main content
. 2019 Sep 19;10:638. doi: 10.3389/fendo.2019.00638

Table 4.

Sensitivity, specificity, and accuracy of GH peaks to GH stimulation tests isolated and in association with IGF-1 SDS for the diagnosis of IGHD.

CP ITT (%) ITT or IGF-1 <−2SD (%) ITT or IGF-1 <−1SD (%) CT (%) CT or IGF-1 <−2SD (%) CT or IGF-1 <−1SD (%) ITT plus CT (%)
<3 μg/L Sens 38.8 42.9 53.1 38.6 45.5 54.6 22.9
Spec 50 90.9 63.6 63.2 84.2 79 76.9
Accu 42.3 57.8 56.3 46 57.1 61.9 37.5
<5 μg/L Sens 81.6 81.6 81.6 70.5 75 79.6 62.9
Spec 36.4 81.8 54.6 36.8 79 68.4 69.2
Accu 67.6 81.7 73.2 60.3 76.2 76.2 64.6
<7 μg/L Sens 93.9 93.9 93.9 93.2 93.2 95.5 88.6
Spec 22.7 81.8 45.5 26.3 68.4 57.9 53.9
Accu 71.8 90.1 78.9 73 85.7 84.1 79.2
<10 μg/L Sens 95.9 95.9 95.9 93.2 93.2 95.5 91.4
Spec 13.6 81.8 40.9 26.3 68.4 57.9 46.2
Accu 70.4 91.6 78.9 73 85.7 84.1 79.2

CP, Cut-off point; GH, Growth Hormone; IGF-1 SDS, Insulin-like Growth Factor 1 Standard Deviations; IGF-1, Insulin-like Growth Factor 1; IGHD, Idiopathic Growth Hormone Deficiency; ITT, Insulin Tolerance Test; CT, Clonidine Test; Sens, sensitivity; Spec, specificity; Accu, accuracy.